Takao Fujii

Author PubWeight™ 48.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Rheumatol 2010 2.53
2 Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum 2009 1.69
3 The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 2009 1.62
4 Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 2006 1.59
5 Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum 2004 1.32
6 Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006 1.27
7 Neutrophils are essential as a source of IL-17 in the effector phase of arthritis. PLoS One 2013 1.15
8 Anammox organism KSU-1 expresses a NirK-type copper-containing nitrite reductase instead of a NirS-type with cytochrome cd1. FEBS Lett 2012 1.14
9 Isolation of a multiheme protein with features of a hydrazine-oxidizing enzyme from an anaerobic ammonium-oxidizing enrichment culture. Appl Environ Microbiol 2006 1.13
10 Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology (Oxford) 2010 1.10
11 DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins. FEBS J 2010 1.10
12 Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis. PLoS One 2013 1.07
13 Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. J Rheumatol 2011 1.00
14 A mono-2-ethylhexyl phthalate hydrolase from a Gordonia sp. that is able to dissimilate di-2-ethylhexyl phthalate. Appl Environ Microbiol 2006 1.00
15 Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012 1.00
16 Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 2014 0.98
17 Three groups in the 28 joints for rheumatoid arthritis synovitis--analysis using more than 17,000 assessments in the KURAMA database. PLoS One 2013 0.98
18 Another multiheme protein, hydroxylamine oxidoreductase, abundantly produced in an anammox bacterium besides the hydrazine-oxidizing enzyme. J Biosci Bioeng 2008 0.95
19 Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Lett 2012 0.95
20 Successful treatment with tocilizumab in a case of intralymphatic histiocytosis associated with rheumatoid arthritis. Intern Med 2014 0.94
21 Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules. Ann Rheum Dis 2012 0.92
22 Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease. Arthritis Rheum 2010 0.90
23 Ozone decomposition of 2-methylisoborneol (MIB) in adsorption phase on high silica zeolites with preventing bromate formation. Water Res 2005 0.88
24 Adsorptive ozonation of 2-methylisoborneol in natural water with preventing bromate formation. Water Res 2005 0.88
25 Successful treatment of a patient with refractory adult Still's disease by tacrolimus. Mod Rheumatol 2007 0.88
26 Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res 2005 0.87
27 Therapeutic response of patients with adult Still's disease to biologic agents: multicenter results in Japan. Mod Rheumatol 2011 0.85
28 The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database. Rheumatol Int 2014 0.84
29 Long-term preservation of anammox bacteria. Appl Microbiol Biotechnol 2011 0.83
30 Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup. J Rheumatol 2003 0.83
31 A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders. J Rheumatol 2013 0.83
32 Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther 2012 0.81
33 Development of a fixed-bed anammox reactor with high treatment potential. Biodegradation 2012 0.81
34 Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice. J Immunol 2014 0.81
35 Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro. Int Immunol 2005 0.81
36 High-rate partial nitrification treatment of reject water as a pretreatment for anaerobic ammonium oxidation (anammox). Bioresour Technol 2010 0.80
37 A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept. Clin Rheumatol 2011 0.80
38 The clinical characteristics of two anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibody-positive interstitial lung disease patients with polymyositis/dermatomyositis. Intern Med 2012 0.79
39 Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals. PLoS One 2011 0.79
40 Molecular characterization of a Rhodotorula-lytic enzyme from Paecilomyces lilacinus having beta-1,3-mannanase activity. Biosci Biotechnol Biochem 2004 0.79
41 Periodic fever and erythema nodosum associated with MDS with trisomy 8: report of two cases and review of the literature. Mod Rheumatol 2010 0.78
42 Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura. Mod Rheumatol 2011 0.78
43 Successful treatment of primary Sjögren's syndrome with chronic natural killer lymphocytosis by high-dose prednisolone and indomethacin farnesil. Intern Med 2007 0.78
44 Pseudoscleroderma associated with transforming growth factor beta1-producing advanced gastric carcinoma: comment on the article by Varga. Arthritis Rheum 2003 0.78
45 A heterodimeric cytochrome c complex with a very low redox potential from an anaerobic ammonium-oxidizing enrichment culture. FEMS Microbiol Lett 2010 0.78
46 Removal of copper from aqueous solution using iron-containing adsorbents derived from methane fermentation sludge. J Hazard Mater 2009 0.78
47 Aseptic meningitis in mixed connective tissue disease: cytokine and anti-U1RNP antibodies in cerebrospinal fluids from two different cases. Mod Rheumatol 2008 0.78
48 Serum IgG levels demonstrate seasonal change in connective tissue diseases: a large-scale, 4-year analysis in Japanese. Mod Rheumatol 2011 0.78
49 Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study. Arthritis Res Ther 2011 0.78
50 High-rate partial nitrification performance of high ammonium containing wastewater under low temperatures. Bioresour Technol 2009 0.77
51 A histopathologic study of mechanic's hands associated with dermatomyositis: a report of five cases. Int J Dermatol 2009 0.77
52 Partial nitrification treatment for high ammonium wastewater from magnesium ammonium phosphate process of methane fermentation digester liquor. J Biosci Bioeng 2009 0.77
53 Case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis. Respir Investig 2012 0.77
54 Effect of salt concentration in anammox treatment using non woven biomass carrier. J Biosci Bioeng 2009 0.76
55 Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men. Mod Rheumatol 2010 0.76
56 Anammox process for synthetic and practical wastewater treatment using a novel kind of biomass carriers. Water Sci Technol 2008 0.75
57 Development of an in vitro batch-type closed gas exposure device with an alveolar epithelial cell line, A549, for toxicity evaluations of gaseous compounds. Anal Sci 2008 0.75
58 Treatment capability of an up-flow anammox column reactor using polyethylene sponge strips as biomass carrier. J Biosci Bioeng 2010 0.75
59 Issues associated with the Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitides: Reclassification of patients in the prospective cohort study of Remission Induction Therapy in Japanese patients with ANCA-associated vasculitides according to the MHLW criteria. Mod Rheumatol 2014 0.75
60 [Neuropsychiatric systemic lupus erythematosus]. Nihon Rinsho 2015 0.75
61 NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA. Mod Rheumatol 2012 0.75
62 Reject water treatment by improvement of whole cell anammox entrapment using polyvinyl alcohol/alginate gel. Biodegradation 2011 0.75
63 [111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Immunity and diseases in internal medicine--Frontier of pathophysiology and treatment; 5) Frontiers in the pathogenesis and treatment of ANCA-associated vasculitis]. Nihon Naika Gakkai Zasshi 2014 0.75
64 Efficacy and Safety of Grapefruit Juice Intake Accompanying Tacrolimus Treatment in Connective Tissue Disease Patients. Intern Med 2016 0.75
65 The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis. Mod Rheumatol 2011 0.75
66 [Anti-histone antibodies]. Nihon Rinsho 2010 0.75
67 High-rate nitrogen removal from anaerobic digester liquor using an up-flow anammox reactor with polyethylene sponge as a biomass carrier. J Biosci Bioeng 2010 0.75
68 A case of Behçet's disease developing after poststreptococcal acute glomerulonephritis. Mod Rheumatol 2012 0.75
69 Partial nitritation treatment of underground brine waste with high ammonium and salt content. J Biosci Bioeng 2009 0.75
70 Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus. Mod Rheumatol 2014 0.75
71 Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy. Nihon Rinsho Meneki Gakkai Kaishi 2016 0.75
72 Adsorption and decomposition of water-dissolved ozone on high silica zeolites. Water Res 2004 0.75
73 A rapid and simple evaluation system for gas toxicity using luminous bacteria entrapped by a polyion complex membrane. Chemosphere 2009 0.75
74 [111th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: 1. Immunity and diseases in internal medicine--Frontier of pathophysiology and treatment; 3) Pathophysiology and the recent treatment of rheumatoid arthritis]. Nihon Naika Gakkai Zasshi 2014 0.75
75 Decomposition of trichloroethene on ozone-adsorbed high silica zeolites. Water Res 2004 0.75
76 [Rheumatology: Progress in Diagnosis and Treatments. Topics: I. Progress in Diagnostic Method; 1. Autoantibodies in systemic rheumatic diseases]. Nihon Naika Gakkai Zasshi 2014 0.75
77 Identification of bacteria coexisting with anammox bacteria in an upflow column type reactor. Biodegradation 2008 0.75
78 Severe subcutaneous generalized edema in a patient with dermatomyositis. Mod Rheumatol 2007 0.75
79 Factors affecting the treatment of reject water by the anammox process. Bioresour Technol 2011 0.75
80 Severe erosive arthropathy requiring surgical treatments in systemic lupus erythematosus. Mod Rheumatol 2009 0.75
81 [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: II. Pathophysiology; 3. Autoantibodies in rheumatoid arthritis]. Nihon Naika Gakkai Zasshi 2012 0.75